Varmus votes - how will you?

Tomorrow is Super Tuesday, so who are you going to vote for? Yesterday, Harold Varmus, president of Memorial Sloan-Kettering Cancer Center in New York, told Wired that he linkurl:plans to cast his ballot;http://blog.wired.com/wiredscience/2008/02/harold-varmus-e.html for Senator Barack Obama on Tuesday, February 5. Obama represents "a new kind of leader, one without ties to a divisive past and one who portrays through his personal history a global perspective that is both crucial and unprec

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Tomorrow is Super Tuesday, so who are you going to vote for? Yesterday, Harold Varmus, president of Memorial Sloan-Kettering Cancer Center in New York, told Wired that he linkurl:plans to cast his ballot;http://blog.wired.com/wiredscience/2008/02/harold-varmus-e.html for Senator Barack Obama on Tuesday, February 5. Obama represents "a new kind of leader, one without ties to a divisive past and one who portrays through his personal history a global perspective that is both crucial and unprecedented," linkurl:Varmus;http://www.the-scientist.com/article/display/23543/ said in a statement. Publications and Web sites are scrambling to tell scientists linkurl:how their candidates and representatives are weighing in;http://www.the-scientist.com/blog/display/54178/ on science; now we want to know what you think. Who are you going to vote for, and why? Click linkurl:here;http://www.the-scientist.com/forum/addcomment/54278/ to tell us. (An interesting aside: Varmus endorsed Obama even though he directed the NIH under Clinton's husband, and as a New York senator, she is his representative in Washington. He said he admires her "understanding of the relationship between science and the federal government," and would vote for her if she became the Democratic candidate.)
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies